HC9 Ventures I, L.P.
Late investment periodEmerging manager
Late investment period: first sale Jan 2022, per Form D (fund age approximates vintage)
Limited data: built from SEC filings only.
- Vintage
- 2022
- Fund size
- $83.2M (Form D)
- Stages
- Not stated
- Sectors
- Not stated
- Regions
- Not stated
01 · Thesis
HC9 invests in Seed and Series A healthcare companies, providing capital and industry expertise to help emerging founders refine product-market fit and execute go-to-market strategies in healthcare technology and services.Inferred from the firm's website
02 · Initial check
$832K to $1.39M (estimated from fund size)
Estimated from Form D
03 · Who to approach
Named on this fund's Form D
- Jonathan Gordon, Managing Member of the General Partner
- Charles Falcone, Managing Member of the General Partner
- Richard Lungen, Managing Member of the General Partner
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
No quoted evidence from the firm's website yet.
06 · Sources
Last verified: Oct 28, 2026